Skip to main content
Caplight Logo









Anlong Fund

Anlong Fund

Beijing, Beijinganlongmed.com

Overview

Anlong Fund is a venture capital firm based in China that focuses on early and growth-stage investments in the life sciences and healthcare sectors, including innovative bio-pharmaceuticals and medical devices. The fund targets the Chinese market, driven by factors like population aging and medical reform. It has at least two funds, Anlong I and Anlong II.

Portfolio Companies

12

Investments

Anlong Fund investments
CompanyDateStageLead
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.Mar 2021AngelCo-investor
Skynor MedicalFeb 2021Series BCo-investor
Beijing Anlong Biopharmaceutical Co., Ltd.Jan 2021VC RoundCo-investor
Beijing CorreGene Biotechnology Co., Ltd.Dec 2019AngelCo-investor
Artivila BiopharmaNov 2019AngelCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?